Elequin Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-195	Closed	-$19K	–	631
2022 Q2	$19K	Buy	195 +19	+11%	+$1.85K	﹤0.01%	197
2022 Q1	$17K	Buy	+176	New	+$17K	﹤0.01%	131